APGE
Apogee Therapeutics, Inc.
135.10$
+0.0%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Cash Flow
Apogee Therapeutics, Inc. (APGE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -71 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | -30 | -32 | -29 | -43 | -68 | -48 | -62 | -54 | -63 | -56 | -71 | -244 | |
| 0.0 | – | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 1.6 | |
| 1.5 | 2.2 | 4.2 | 5.7 | 5.8 | 7.6 | 11 | 11 | 12 | 12 | 17 | 17 | 58 | |
| -0.3 | 2.5 | -1.3 | 1.5 | 3.7 | -6.0 | -2.9 | -6.8 | -0.8 | -4.9 | 1.5 | -8.8 | -13 | |
| 0.0 | 0.2 | 0.4 | 0.1 | 0.8 | 0.0 | 4.3 | 0.8 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | |
| -234 | -274 | -52 | -149 | -146 | 46 | 13 | 78 | 18 | -289 | -35 | -382 | -688 | |
| – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | |
| 317 | -0.2 | 451 | -0.2 | 0.4 | 44 | 0.6 | 1.2 | 20 | 375 | 411 | 107 | 913 | |
| 63 | -70 | 367 | -178 | -189 | 23 | -35 | 17 | -17 | 24 | 320 | -346 | -19 | |
| -20 | -30 | -32 | -29 | -43 | -68 | -53 | -63 | -54 | -63 | -56 | -71 | -244 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.